Filter announcements
Loading...
Themis Medicare is principally engaged in the activities pertaining to manufacturing of pharmaceutical products, especially in Formulation and API activity.
Themis Medicare Limited has informed the Exchange about Copy of Newspaper Publication for Notice of 56th AGM scheduled on 30th September, 2026.
Themis Medicare Limited has informed the Exchange regarding Notice of 56th Annual General Meeting to be held on September 30, 2026
Significant increase in volume has been observed in Themis Medicare Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Themis Medicare Limited has...
Themis Medicare updated investor communication channels. It changed the email ID for its Company Secretary/Compliance Officer and also updated the email for its Registrar and Share Transfer Agent (RTA).
Themis Medicare Limited has informed the Exchange about Copy of Newspaper Publication